Showing results (51-60 of 988) with videos related to
Sort By:
Pageof 99
Asia Pacific Allergy|November 6, 2015
Making allergic and hypersensitivity conditions visible in the International Classification of Diseases-11Luciana Kase Tanno, Moises A Calderon, Pascal DemolyCurrent Opinion in Allergy and Clinical Immunology|September 18, 2007
Hypersensitivity reactions to biological agents with special emphasis on tumor necrosis factor-alpha antagonistsPaolo Campi, Maurizio Benucci, Mariangela Manfredi, et al.Clinical and Translational Allergy|October 11, 2013
Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort surveyMark Small, James Piercy, Pascal Demoly, et al.BMC Pulmonary Medicine|May 25, 2016
"A year-long, fortnightly, observational survey in three European countries of patients with respiratory allergies induced by house dust mites: Methodology, demographics and clinical characteristics"Pascal Demoly, Andrea Matucci, Oliviero Rossi, et al.Current Opinion in Allergy and Clinical Immunology|January 28, 2020
How molecular allergology can shape the management of allergic airways diseasesDavide Caimmi, Enrica Manca, Elena Carboni, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 1, 2009
Desloratadine for the treatment of cypress pollen-induced allergic rhinitisPascal Demoly, Isabelle Dreyfus, Henriette Dhivert-Donnadieu, et al.Current Opinion in Allergy and Clinical Immunology|July 19, 2022
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deathsLuciana K Tanno, Amélie Gauthier, Salome Allichon, et al.Clinical and Translational Allergy|September 5, 2015
Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and backRik Schrijvers, Liesbeth Gilissen, Anca Mirela Chiriac, et al.Current Opinion in Allergy and Clinical Immunology|June 26, 2023
Drug allergy in primary care: systematic review to support quality improvement initiative of management and optimization of healthcare pathwaysClara Gaudin, Dermot Ryan, Pascal Demoly, et al.Clinical and Translational Allergy|December 25, 2015
Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dosePascal Demoly, Gianni Passalacqua, Moises A Calderon, et al.Pageof 99